Listen to Addiction Psychiatrist Elizabeth “Libby” Stuyt’s discussion on High Truths on Drugs and Addiction, Episode #58

High potency THC is associated with psychosis and schizophrenia. Why are we not following the science? Join us with Dr. Elizabeth Stuyt as we discuss the concerning increase of THC potency in cannabis and how it can affect our brain. Increased paranoia, psychosis, and schizophrenia are examples of conditions we are seeing more and more of in our emergency rooms. When the toxicology report comes back, the only drug in their system is the high potency THC cannabis.

Listen Now

About Elizabeth ‘Libby’ Stuyt, MD
Dr. Stuyt is a board-certified Addiction Psychiatrist and has worked in the addiction/behavioral health field since 1990. She was the Medical Director for the Circle Program, a 90-day inpatient treatment program, funded by the state of Colorado, for persons with co-occurring mental illness and substance abuse who have failed other levels of treatment from 1999 to 2020. She retired from this position in May 2020 in order to spend more time attempting to educate as many people as possible on the un-intended consequences she has seen from the commercialization of marijuana in Colorado, focusing primarily on the deleterious effects of high potency THC on the developing brain and mental health.

Listen to Episode #58 Now

 

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top